Concepedia

Hiroaki Ikeda

HI

Statistics

Publications

81

Citations

7.3K

H-Index

38

Active since

1976

Affiliations

Mie University(Current)

Nagasaki University

Hokkaido University

Takara (Japan)

Hiroshima University Hospital

Hiroaki Ikeda is an author at Mie University specializing in immunology, oncology, and cancer immunotherapy.

ORCID

Publications per year

1976–2023

81

Publications

81

IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Vijay Shankaran, Hiroaki Ikeda, Allen T. Bruce et al. · Nature · 2001 · 2.8K citations

, , +12

Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy

Holly L. Hanson, David L. Donermeyer, Hiroaki Ikeda et al. · Immunity · 2000 · 350 citations · Full text

, , +12

Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells

Naohiro Seo, Yoshitaka Shirakura, Yoshiro Tahara et al. · Nature Communications · 2018 · 249 citations · Full text

, , +17

Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR

Sachiko Okamoto, Junichi Mineno, Hiroaki Ikeda et al. · Cancer Research · 2009 · 184 citations

, , +17

Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer

Shinichi Kageyama, Hiroaki Ikeda, Yoshihiro Miyahara et al. · Clinical Cancer Research · 2015 · 179 citations

, , +17

1–5 of 81